Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. Amitani M, Oba T, Kiyosawa N, Morikawa H, et al. BMC Cancer 2022;22:327.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amitani M, Oba T, Kiyosawa N, Morikawa H, et al. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer 2022;22:327.
PMID: 35346102